Drugs / Quadrivalent Influenza Vaccine High Dose
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06744205 Comparator | Jan 2025 → May 2026 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Quadrivalent Influenza Vaccine High Dose | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06744205 ↗ |
| Modality | Vaccine | “QIV-HD vaccine” NCT06744205 ↗ |
| Route | Intramuscular | “Route of administration: Intramuscular injection” NCT06744205 ↗ |